Ensuring that CLL research and treatments are accessible to all patients, regardless of their background, is the only way to improve and advance both research and treatment of CLL. 

A recent study gathered the data from more than 12,000 patients with CLL in the US and discovered that, after 8 years since diagnosis, Black patients and people with lower income passed away sooner than White patients and those with higher income. Research confirms that when access to cancer care is equal, racial disparities are alleviated. 

The only way to fully understand how CLL is being treated in the real world and the differences between individuals living with the disease is by having patients contribute to research and agree to share their data with researchers.

Platforms like HealthTree Cure Hub Registry empower patients to play an active role in CLL research. By securely and anonymously sharing your health data, you contribute to a deeper understanding of CLL and help accelerate the development of new treatments. 

Create Your Free Account